Management of Bradycardia and Presyncope in Post-Ablation Patients
Assessment and Immediate Management
- The American College of Cardiology suggests that patients experiencing presyncope with sinus bradycardia after cardiac ablation for atrial fibrillation may be experiencing medication-induced bradycardia, a common side effect of both flecainide and beta-blockers 1, 3, 4
- The American Heart Association recommends reducing or discontinuing metoprolol while maintaining flecainide therapy as a first-line approach for managing symptomatic bradycardia in post-ablation patients, as beta-blockers are more likely contributing to the bradycardia 2, 4
- If bradycardia persists after metoprolol adjustment, consider reducing flecainide dose from 150mg BID to 100mg BID, as flecainide can also cause bradycardia and conduction disturbances 5, 6
Rationale and Follow-up
- The American College of Cardiology recommends monitoring the patient closely with ECG after medication adjustments to ensure adequate heart rate response and resolution of symptoms, and reassessing the patient within 1-2 weeks to evaluate heart rate and symptoms 6
- The European Heart Society suggests that if symptoms persist despite medication adjustments, consideration should be given to further reduction of flecainide dose, evaluation for possible sinus node dysfunction, or consideration of pacemaker if significant symptomatic bradycardia persists despite medication adjustments 2